See more : Unity Biotechnology, Inc. (UBX) Income Statement Analysis – Financial Results
Complete financial analysis of Innovation1 Biotech Inc. (IVBT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Innovation1 Biotech Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- SSH Group Limited (SSH.AX) Income Statement Analysis – Financial Results
- NAYA Biosciences, Inc. (NAYA) Income Statement Analysis – Financial Results
- Paycom Software, Inc. (0KGH.L) Income Statement Analysis – Financial Results
- Greenyn Biotechnology Co., Ltd (6846.TWO) Income Statement Analysis – Financial Results
- Sinew Pharma Inc. (6634.TWO) Income Statement Analysis – Financial Results
Innovation1 Biotech Inc. (IVBT)
About Innovation1 Biotech Inc.
Innovation1 Biotech Inc., a drug discovery company, focuses on the development of modified schedule 1 molecules of botanical origin in the United States. Its portfolio includes five proprietary fully synthetic preclinical prodrugs addressing independent clinical indications comprising a mushroom-derived psychedelic molecule for treatment of post-traumatic stress disorder and depression; a novel cannabinoid and tree bark derived psychedelic for treatment of addiction; and three additional cannabinoid prodrugs addressing clinical indications of refractory pediatric epilepsy, hypertrophic scarring, and ocular inflammation. The company was formerly known as Gridiron BioNutrients, Inc. and changed its name to Innovation1 Biotech Inc. in March 2022. Innovation1 Biotech Inc. was founded in 2014 and is headquartered in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 3.08K | 1.18K | 79.25K | 16.77K | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 52.70K | 2.55M | 1.42K | 2.96K | 129.34K | 81.03K | 0.00 | 0.00 | 0.00 |
| Gross Profit | -52.70K | -2.55M | 1.66K | -1.78K | -50.09K | -64.25K | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 53.86% | -150.97% | -63.21% | -383.13% | 0.00% | 0.00% | 0.00% |
| Research & Development | 15.00K | 201.17K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 685.45K | 2.50M | 239.97K | 212.43K | 522.33K | 310.05K | 21.68K | 0.00 | 0.00 |
| Selling & Marketing | 10.27K | 4.91K | 677.00 | 2.66K | 94.44K | 61.81K | 14.18K | 0.00 | 0.00 |
| SG&A | 1.20M | 2.50M | 240.65K | 215.10K | 616.78K | 371.86K | 35.85K | 35.01K | 14.52K |
| Other Expenses | 101.05K | 0.00 | 8.35K | -821.14K | -23.28K | -674.01K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.37M | 5.25M | 240.65K | 215.10K | 616.78K | 371.86K | 35.85K | 35.01K | 14.52K |
| Cost & Expenses | 1.37M | 5.25M | 242.07K | 218.06K | 746.11K | 452.89K | 35.85K | 35.01K | 14.52K |
| Interest Income | 0.00 | 13.64K | 55.57K | 41.25K | 23.86 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 251.83K | 5.51K | 220.02K | 1.30M | 587.00 | 1.52K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 52.70K | 2.55M | 1.41K | 2.61K | 1.92K | 530.00 | 161.71K | 22.82K | 0.00 |
| EBITDA | -5.68M | -38.33M | -257.03K | -1.28M | -167.57K | -973.48K | 0.00 | 0.00 | -14.52K |
| EBITDA Ratio | 0.00% | 0.00% | -5,638.34% | -84,179.59% | -868.47% | -6,616.18% | 0.00% | 0.00% | 0.00% |
| Operating Income | -1.37M | -41.03M | -238.99K | -216.88K | -667.99K | -436.12K | -35.85K | -35.01K | -14.52K |
| Operating Income Ratio | 0.00% | 0.00% | -7,759.45% | -18,363.93% | -842.93% | -2,600.43% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -4.62M | -35.63M | 1.28M | -2.36M | 456.66K | -539.41K | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -5.99M | -40.88M | 1.04M | -2.58M | -170.07K | -975.52K | -35.85K | -35.01K | -14.52K |
| Income Before Tax Ratio | 0.00% | 0.00% | 33,764.03% | -218,464.69% | -214.61% | -5,816.73% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 2.41M | 228.37K | 476.11K | -22.69K | -672.50K | -161.71K | -22.81K | 0.00 |
| Net Income | -5.99M | -40.88M | 811.56K | -3.06M | -147.38K | -303.03K | -35.85K | -35.01K | -14.52K |
| Net Income Ratio | 0.00% | 0.00% | 26,349.35% | -258,778.92% | -185.97% | -1,806.86% | 0.00% | 0.00% | 0.00% |
| EPS | -0.70 | -2.68 | 4.31 | -10.18 | -0.34 | -0.75 | -0.20 | -0.20 | -0.09 |
| EPS Diluted | -0.70 | -2.68 | 4.31 | -10.18 | -0.34 | -0.75 | -0.20 | -0.20 | -0.09 |
| Weighted Avg Shares Out | 20.18M | 15.23M | 188.09K | 300.26K | 436.04K | 406.36K | 179.10K | 170.91K | 170.91K |
| Weighted Avg Shares Out (Dil) | 20.18M | 15.23M | 188.09K | 300.26K | 436.04K | 406.39K | 179.10K | 170.91K | 170.91K |
Source: https://incomestatements.info
Category: Stock Reports